SHR-8068
Drug timelines are a Plus or Pro feature.
13 regulatory and trial events tracked for SHR-8068, covering 2024-03-28 to 2026-04-08. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study of SHR-A1921 Combined With Adebrelimab and SHR-8068 With or Without Carboplatin in the Treatment of Advanced NSCLC [Phase 1, Phase 2]